Skip to main content
Top

Clinical Oncology and Cancer Research

Issue 4/2010

Content (9 Articles)

What is new in supportive care in cancer?

Qi Wang, Wen Li, Yong-chuan Wang

Experimental study on the mechanism of reversal of leukemia multidrug resistance by proteasome inhibitor bortezomib

Ying-chun Li, Hui-han Wang, Hong-yu Pan, Ai-jun Liao, Wei Yang, Zhuo-gang Liu, Xiao-bin Wang

Prognostic and predictive factors of early breast cancer

Zhong-jie Chen, Mei-ying Yan, Hong-qing Zhuang, Jian-lei Hao, Rui-ying Li, Zhi-yong Yuan, Ping Wang

Detection of Syndecan-1 and heparanase-1 genes in esophageal carcinoma by quantitative RT-PCR

Jun-li Si, Yu-qin Qi, Jing-yuan Cui, Song-mei Wang, He Wang, Mei Lü

Rehabilitation effect of systematic exercise on breast cancer patients after adjuvant chemotherapy

Wan-min Qiang, Feng-qi Dong, Ling Yan, Yu-hong Chen, Lei Tang, Yong-qin Jiang

Empirical study on chemotherapeutic susceptibility of SP cells in human pulmonary adenocarcinoma cell line A549 in Vitro

Tong Xie, Li Li, De-seng Liu, Nai-quan Mao, Dan-rong Li, Chuan-tian Zuo, Ding-ming Huang

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine